The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis

BACKGROUND: Production of the chemokine CCL2 by cells of the neurovascular unit (NVU) drives critical aspects of neuroinflammation. Suppression of CCL2 therefore holds promise in treating neuroinflammatory disease. Accordingly, we sought to determine if the compound bindarit, which inhibits CCL2 syn...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ge, Shujun, Shrestha, Bandana, Paul, Debayon, Keating, Carolyn, Cone, Robert, Guglielmotti, Angelo, Pachter, Joel S
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2012
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488971/
https://ncbi.nlm.nih.gov/pubmed/22788993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-9-171
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk